Compartir

Acceso a las Pruebas de Biomarcadores Press Releases

11 de Marzo de 2026

‘Delaware Advocacy Day’ Brings Patient Advocates to Dover to Discuss Affordability of Biomarker Testing

Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of ‘Delaware Advocacy Day.’ The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer’s Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans’ access to biomarker testing.

11 de Marzo de 2026

NYS Senate Rejects Medicaid Rollback of Biomarker Testing Coverage Criteria, Patient Advocates Urge Governor & Assembly to Follow Suit in Final Budget

The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.